nybanner

        Products

        API-Drug Peptide Ziconotide/OMEGA-CGTX MVII A N-type calcium channel blocker

        Short Description:

        Ziconotide is an artificial synthesis of hydrophilic polypeptide ω-MVIIA in the venom peptide of Pacific fish-eating snail-chicken heart snail, and it is the first new non-opioid ?druganalgesic to be used in clinic. Ziconotide ?can be used as a non-opioid analgesic drug for intrathecal administration.?


        Product Detail

        Product Tags

        About This Item

        It is suitable for intrathecal injection and other treatment methods (such as systemic analgesics, adjuvant therapy or sheath) Ziconotide is a powerful, selective and reversible N-type voltage-sensitive calcium channel blocker, which is effective for refractory pain, and does not produce drug resistance after long-term administration, and it does not cause physical and mental dependence, nor does it cause life-threatening respiratory depression due to overdose. The recommended daily dose is less, with good curative effect, high safety, less adverse reactions, no drug resistance and addiction. This product has a huge market prospect as a painkiller.

        Product Dispaly

        IMG_20200609_154048
        IMG_20200609_155449
        IMG_20200609_161417

        Why Choose Us

        According to incomplete statistics, the incidence of pain in the world is about 35% ~ 45% at present, and the incidence of pain in the elderly is relatively high, about 75% ~ 90%. An American survey shows that the incidence of migraine increased from 23.6 million in 1989 to 28 million in 2001. In the investigation of chronic pain in six cities in China, it is found that the incidence of chronic pain in adults is 40%, and the rate of medical treatment is 35%; The incidence of chronic pain in the elderly is 65% ~ 80%, and the rate of seeing a doctor is 85%. In recent years, the medical expenses for pain relief are increasing year by year.
        From 2013 to July 2015, the Pain Research Center in the United States and several medical institutions conducted a long-term, multi-center and observational study on intrathecal injection of ziconotide in 93 adult white female patients with severe chronic pain. The pain digital score scale and the overall sensory score of patients with intrathecal injection of ziconotide and without injection of ziconotide were compared Among them, 51 patients used intrathecal injection of ziconotide, while 42 patients did not. The baseline pain scores were 7.4 and 7.9, respectively. The recommended dose of intrathecal injection of ziconotide was 0.5-2.4 mcg/ day, which was adjusted according to the patient's pain response and side effects. The average initial dose was 1.6 mcg/ day, 3.0 mcg/ day at 6 months and 2.5 at 9 months. At 12 months, it was 1.9 mcg/ day, and after 6 months, the decrease rate was 29.4%, the contrast increase rate was 6.4%, and the improvement rate of overall sensory score was 69.2% and 35.7% respectively. After 12 months, the decrease rate was 34.4% and 3.4% respectively, and the improvement rate of overall sensory score was 85.7% and 71.4% respectively. The highest side effects were nausea (19.6% and 7.1%), hallucination (9.8% and 11.9%) and dizziness (13.7% and 7.1%). The results of this study once again confirmed the effectiveness and safety of ziconotide recommended as a first-line intrathecal injection.

        The preliminary study on ziconotide can be traced back to the 1980s, when the potential therapeutic application of rigid and protein-like peptides in conus venom was explored for the first time. These conotoxins are small peptides rich in disulfide bonds, usually 10-40 residues in length, to target various ion channels, GPCR and transporter proteins efficiently and selectively. Ziconotide is a 25-peptide derived from Conus magus, which contains three disulfide bonds, and its short β-fold is spatially arranged into a unique three-dimensional structure, which allows it to selectively inhibit CaV2.2 channels.


      1. Previous:
      2. Next:

      3. 主站蜘蛛池模板: 久久精品国产99精品国产2021 | 午夜爽爽性刺激一区二区视频| 再深点灬舒服灬太大了短文d| 伊人久久大香线蕉无码| 亚洲国产成人精品女人久久久| 久久精品卫校国产小美女| 中国sで紧缚调教论坛| 99久久精品这里只有精品| 日韩精品一区二区三区老鸭窝| 能在线观看的一区二区三区| 激情久久av一区av二区av三区| 美女被免费网站视频在线| 欧美黑人巨大videos精| 最新亚洲春色av无码专区| 成人无码精品一区二区三区| 国产精品视频观看| 国产一区二区三区影院| 亚洲精品成人片在线播放| 久久人人爽人人爽人人av东京热| a一级毛片免费高清在线| 麻豆乱码国产一区二区三区| 理论片yy4408在线观看| 日本边添边摸边做边爱喷水| 处女的诱惑在线观看| 国产乱了真实在线观看| 亚洲欧美中文字幕5发布| 中文字幕第五页| 女警骆冰被黑人调教免费阅读小说 | 人妻少妇精品视频一区二区三区 | 女人18片毛片60分钟| 好吊妞最新视频免费观看| 国产片免费福利片永久| 伊人中文字幕在线观看| 中文字幕精品无码一区二区三区| 四虎国产精品永久在线播放| 真精华布衣3d1234正版图2020/015| 欧美乱妇高清无乱码免费| 日本精品a在线| 少妇人妻偷人精品一区二区| 国产精品国产国产aⅴ| 国产又黄又硬又粗|